Ropinirole KRKA 2mg – 28 Prolonged Release Tablets
Steady Dopamine Support for Parkinson’s Disease & Restless Legs Syndrome
Ropinirole KRKA 2mg Prolonged Release is a prescription medication used to manage symptoms of Parkinson’s disease and Restless Legs Syndrome (RLS). As a dopamine agonist, ropinirole mimics the action of dopamine in the brain, helping to improve movement control and reduce discomfort caused by dopamine deficiency.
The prolonged-release formulation ensures gradual and consistent release of the medicine over 24 hours. This helps provide smoother symptom control, reduce “off” periods, and improve daily functioning for patients living with chronic neurological conditions.
Ropinirole may help reduce symptoms such as tremors, stiffness, slowed movement, and restless sensations in the legs, supporting greater independence and comfort.
Key Benefits
- ✅ Supports management of Parkinson’s disease symptoms
- ✅ Helps relieve Restless Legs Syndrome (RLS)
- ✅ Prolonged-release formula for steady, once-daily control
- ✅ Improves movement and reduces stiffness
- ✅ Suitable for long-term neurological care
Who Is It For?
- Adults diagnosed with Parkinson’s disease
- Individuals experiencing moderate to severe RLS
- Patients requiring consistent dopamine support
- Use strictly under neurologist supervision
Ropinirole KRKA 2mg Prolonged Release helps restore movement balance and comfort — offering steady support for daily neurological care.
Prescription-only medicine. Do not stop or adjust dose without consulting your healthcare provider.